免疫疗法效率的有效预测器:通过纳米粒子载入整个瘤抗原来检测血液中的泛克隆效应器瘤抗原特异性T细胞

Weibiao Zeng1,2,3,4,5, Jin Wang2,5, Zhike Chen1,3,5

  • 1Institute of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, Jiangsu, 215123, P. R. China.

概括

现在可以量化瘤特异性免疫力. 测量效应因子瘤抗原特异性T细胞 (ETASTs) 准确预测肺癌患者的免疫治疗反应.